QuidelOrtho (QDEL) Total Non-Current Liabilities (2022 - 2026)
QuidelOrtho (QDEL) posted Total Non-Current Liabilities of $3.7 billion for Q1 2026, little changed sequentially from $3.7 billion in Q4 2025, and up 7.96% YoY from $3.4 billion in Q1 2025.
QuidelOrtho (QDEL) Total Non-Current Liabilities (2022 - 2026) Analysis & Trends
QuidelOrtho has reported Total Non-Current Liabilities for 5 years, with the latest figure at $3.7 billion in Q1 2026.
- Quarterly Total Non-Current Liabilities rose 7.96% year-over-year to $3.7 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.7 billion (up 7.96% YoY) and the FY2025 annual result came in at $3.7 billion, up 8.82% from the prior year.
- Total Non-Current Liabilities held at $3.7 billion in Q1 2026 per QDEL's latest filing, from $3.7 billion in the prior quarter.
- Over five years, Total Non-Current Liabilities peaked at $3.8 billion in Q1 2023 and troughed at $452.5 million in Q1 2022.
- A 5-year average of $3.4 billion and a median of $3.5 billion in 2024 frame the typical range for Total Non-Current Liabilities.
- The sharpest annual moves came in 2023 and 2024: Total Non-Current Liabilities jumped 748.04% in 2023, then decreased 9.55% in 2024.
- Over 5 years, Total Non-Current Liabilities stood at $3.8 billion in 2022, then decreased by 7.95% to $3.5 billion in 2023, then fell by 2.59% to $3.4 billion in 2024, then increased by 8.82% to $3.7 billion in 2025, then retreated by 0.48% to $3.7 billion in 2026.
- According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $3.7 billion, $3.7 billion, and $3.5 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 21.28 Bn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 40.90 Bn |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | 42.74 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 2.57 Bn |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | 3.68 Bn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | 23.89 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 9.07 Bn |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | 3.44 Bn |
| 10 | QuidelOrtho | 1.01 Bn | 885.05 Mn | - | 3.80 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 28, 2026 | 3.80 Bn |
| Mar 29, 2026 | 3.66 Bn |
| Dec 28, 2025 | 3.68 Bn |
| Sep 28, 2025 | 3.50 Bn |
| Jun 29, 2025 | 3.45 Bn |
| Mar 30, 2025 | 3.39 Bn |
| Dec 29, 2024 | 3.38 Bn |
| Sep 29, 2024 | 3.50 Bn |
| Jun 30, 2024 | 3.45 Bn |
| Mar 31, 2024 | 3.33 Bn |
| Dec 31, 2023 | 3.47 Bn |
| Oct 1, 2023 | 3.51 Bn |
| Jul 2, 2023 | 3.48 Bn |
| Apr 2, 2023 | 3.68 Bn |
| Jan 1, 2023 | 3.84 Bn |
| Oct 2, 2022 | 3.77 Bn |
| Jul 3, 2022 | 3.82 Bn |
| Jan 2, 2022 | 452.50 Mn |